Key facts
- This page summarizes Daniel Lee Flynn's Form 4 filing for Deciphera Pharmaceuticals, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Jun 2023, 16:05.
Daniel Lee Flynn - 16 Jun 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- N/A
- Reported as of
- 16 Jun 2023
- Net transaction value
- -$23,835
- SEC form
- 4
- Accepted by SEC
- 21 Jun 2023, 16:05:15 UTC
- Prior SEC filing
- 17 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeffrey M. Held, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daniel Lee Flynn filed Form 4 for Deciphera Pharmaceuticals, Inc. on 21 Jun 2023.
Change
- Previous filing in this sequence was filed on 17 Feb 2023.
- Current net transaction value: -$23,835.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DCPH
transaction
Common Stock
Sale
- Transaction value
- $23,835
- Shares
- -1,655
- Change %
- -2.8%
- Price
- $14.40
- Shares after
- 57,158
- Date
- 16 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
DCPH
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 180,947
- Date
- 16 Jun 2023
- Ownership
- By Daniel L. Flynn Revocable Trust
- Footnotes
- F2
DCPH
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 91,020
- Date
- 16 Jun 2023
- Ownership
- By Daniel L. Flynn Irrevocable Trust
DCPH
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 49,488
- Date
- 16 Jun 2023
- Ownership
- By GRAT
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This sale was to cover tax liabilities in the vesting of restricted stock units.
Footnote F2
Reflects shares previously transferred from the Daniel L. Flynn Revocable Trust to the Reporting Person's grantor retained annuity trust.